Q1 report due 29 April We forecast net sales of SEK 589m, EBITA of SEK 92m We lower '25e-'27e EBITA ...
Redeye is pleased to note that Smart Eye announced two new design wins worth SEK200m today with an u...
Redeye comments on NextCell Pharma ahead of the upcoming interim data from ProTrans-Young, set to be...
Redeye initiates coverage of Tradedoubler, a leading digital network within affiliate and influencer...
Redeye provides a brief comment on Ependion’s acquisition of German company Welotec.
Redeye comments on the intriguing news that a newly published article in Nature highlights the poten...
Nosa Plugs AB (“Nosa Plugs” or “the Company”) announced on April 2, 2025, that it has reached its ta...
Den 1 april 2025 meddelade AcuCort (”AcuCort” eller ”Bolaget”) att Bolaget mottagit en ny order på Z...
NoHo Partners has executed on its strategy by separating its subcompany Better Burger Society (BBS) ...
Q1e: Flat organic sales growth, 5.3% adj. EBITA margin Expect Sweden to weigh on growth, awaiting AD...
NoHo Partners is separating its subgroup Better Burger Society from the group, while retaining a maj...
Following the many recent grants, notices of allowance and intention to grant patents in Europe and ...
Redeye comments on Physitrack’s announcement regarding the divestment of its German wellness subsidi...
Redeye previews Enea’s Q1 2025 (due on 24 April 2025).
CMD feedback: Transformation done, now ready to accelerate High-quality Flow Technology segment will...
Q1'25 numbers due on 29 April at 07:45 CET Adj. EBITDA up by 1% for '25e-'27e Fair value range of SE...
Redeye comments on the takeover offer on Fortnox from First Kraft and EQT X.
Redeye updates its estimates following Freemelt’s Q4 report, which came in above our expectations in...
The Board of Directors of Lowwi AB (Skalhuset) has today filed for company reorganization.
Redeye comments on Lipigons third quarter report, including positive phase I results for Leaderna, c...